← Search & browse all drugs
GENITO URINARY SYSTEM AND SEX HORMONES › GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS › ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS › Imidazole derivatives
flutrimazole
G01AF18
Forms & Strengths
- Vaginal cream 1%
- Topical cream 1%
Adult Dosing
- Vulvovaginal candidiasis: 5g of 1% vaginal cream inserted daily for 6 consecutive days
- Dermatomycoses: Apply 1% topical cream to affected areas once or twice daily for 2 to 4 weeks
Pediatric Dosing
- Safety and efficacy in pediatric patients under 12 years have not been established
- Use in adolescents follows adult dosing guidelines if clinically indicated
Indications
- Treatment of vulvovaginal candidiasis
- Treatment of superficial dermatomycoses (tinea corporis, tinea cruris, tinea pedis)
Mechanism of Action
- Broad-spectrum imidazole antifugal agent
- Inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis
- Leads to increased fungal cell membrane permeability and cell lysis
Contraindications
- Hypersensitivity to flutrimazole or other imidazole antifungals
- First trimester of pregnancy (relative contraindication for vaginal formulations)
Adverse Reactions
- Local burning sensation
- Pruritus at application site
- Erythema and local irritation
- Contact dermatitis
Drug Interactions
- Potential for decreased efficacy of latex contraceptives (condoms, diaphragms) due to excipients in vaginal cream
- Minimal systemic absorption limits significant systemic pharmacokinetic drug interactions
Curated Content: Needs Vetting Before Put to Clinical Use